Defining and treating high-risk multiple myeloma

被引：56

作者：

Usmani, S. Z. ^{[1
]}

Rodriguez-Otero, P. ^{[2
]}

Bhutani, M. ^{[1
]}

Mateos, M-V ^{[3
]}

Miguel, J. S. ^{[2
]}

机构：

[1] Carolinas HealthCare Syst, Levine Canc Inst, Dept Hematol Oncol Blood Disorders & Bone Marrow, Charlotte, NC 28204 USA

[2] Univ Navarra Clin, Dept Hematol, CIMA, IDISNA, Navarra, Spain

[3] Univ Hosp Salamanca, IBSAL, Dept Hematol, Salamanca, Spain

来源：

LEUKEMIA | 2015年 / 29卷 / 11期

关键词：

STEM-CELL TRANSPLANTATION; SINGLE-AGENT CARFILZOMIB; GENETIC ABNORMALITIES; INTERGROUPE FRANCOPHONE; RANDOMIZED PHASE-3; PROGNOSTIC-FACTOR; INITIAL THERAPY; STAGING SYSTEM; SURVIVAL; IMPACT;

D O I：

10.1038/leu.2015.209

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multiple myeloma (MM) is more recently being recognized as a heterogeneous group of disease with variability in outcomes based on specific clinical and biologic predictors. MM patients can be broadly categorized into standard, intermediate and high risk for disease relapse, morbidity and mortality. The high-risk features include patient-specific factors such as old age, poor performance status and comorbidities; clinical features such as primary plasma cell leukemia and extramedullary disease; disease-specific biologic features such as deletion 17p, t(4;14) and high-risk gene expression profiling signatures. The current paper reviews the available data on best therapeutic approaches for high-risk MM.

引用

页码：2119 / 2125

页数：7

共 62 条

[1] Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma [J].

Attal, Michel ;

Lauwers-Cances, Valerie ;

Marit, Gerald ;

Caillot, Denis ;

Moreau, Philippe ;

Facon, Thierry ;

Stoppa, Anne Marie ;

Hulin, Cyrille ;

Benboubker, Lofti ;

Garderet, Laurent ;

Decaux, Olivier ;

Leyvraz, Serge ;

Vekemans, Marie-Christiane ;

Voillat, Laurent ;

Michallet, Mauricette ;

Pegourie, Brigitte ;

Dumontet, Charles ;

Roussel, Murielle ;

Leleu, Xavier ;

Mathiot, Claire ;

Payen, Catherine ;

Avet-Loiseau, Herve ;

Harousseau, Jean-Luc .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1782-1791

[2] Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project [J].

Avet-Loiseau, H. ;

Durie, B. G. M. ;

Cavo, M. ;

Attal, M. ;

Gutierrez, N. ;

Haessler, J. ;

Goldschmidt, H. ;

Hajek, R. ;

Lee, J. H. ;

Sezer, O. ;

Barlogie, B. ;

Crowley, J. ;

Fonseca, R. ;

Testoni, N. ;

Ross, F. ;

Rajkumar, S. V. ;

Sonneveld, P. ;

Lahuerta, J. ;

Moreau, P. ;

Morgan, G. .

LEUKEMIA, 2013, 27 (03) :711-717

[3] Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone [J].

Avet-Loiseau, H. ;

Soulier, J. ;

Fermand, J-P ;

Yakoub-Agha, I. ;

Attal, M. ;

Hulin, C. ;

Garderet, L. ;

Belhadj, K. ;

Dorvaux, V. ;

Minvielle, S. ;

Moreau, P. .

LEUKEMIA, 2010, 24 (03) :623-628

[4] Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome [J].

Avet-Loiseau, Herve ;

Attal, Michel ;

Moreau, Philippe ;

Charbonnel, Catherine ;

Garban, Frederic ;

Hulin, Cyrille ;

Leyvraz, Serge ;

Michallet, Mauricette ;

Yakoub-Agha, Ibrahim ;

Garderet, Laurent ;

Marit, Gerald ;

Michaux, Lucienne ;

Voillat, Laurent ;

Renaud, Marc ;

Grosbois, Bernard ;

Guillerm, Gaelle ;

Benboubker, Lotfi ;

Monconduit, Mathieu ;

Thieblemont, Catherine ;

Casassus, Philippe ;

Caillot, Denis ;

Stoppa, Anne-Marie ;

Sotto, Jean-Jacques ;

Wetterwald, Marc ;

Dumontet, Charles ;

Fuzibet, Jean-Gabriel ;

Azais, Isabelle ;

Dorvaux, Veronique ;

Zandecki, Marc ;

Bataille, Regis ;

Minvielle, Stephane ;

Harousseau, Jean-Luc ;

Facon, Thierry ;

Mathiot, Claire .

BLOOD, 2007, 109 (08) :3489-3495

[5] Chromosomal Abnormalities Are Major Prognostic Factors in Elderly Patients With Multiple Myeloma: The Intergroupe Francophone du Myelome Experience [J].

Avet-Loiseau, Herve ;

Hulin, Cyrille ;

Campion, Loic ;

Rodon, Philippe ;

Marit, Gerald ;

Attal, Michel ;

Royer, Bruno ;

Dib, Mamoun ;

Voillat, Laurent ;

Bouscary, Didier ;

Caillot, Denis ;

Wetterwald, Marc ;

Pegourie, Brigitte ;

Lepeu, Gerard ;

Corront, Bernadette ;

Karlin, Lionel ;

Stoppa, Anne-Marie ;

Fuzibet, Jean-Gabriel ;

Delbrel, Xavier ;

Guilhot, Francois ;

Kolb, Brigitte ;

Decaux, Olivier ;

Lamy, Thierry ;

Garderet, Laurent ;

Allangba, Olivier ;

Lifermann, Francois ;

Anglaret, Bruno ;

Moreau, Philippe ;

Harousseau, Jean-Luc ;

Facon, Thierry .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (22) :2806-+

[6] Long-Term Analysis of the IFM 99 Trials for Myeloma: Cytogenetic Abnormalities [t(4;14), del(17p), 1q gains] Play a Major Role in Defining Long-Term Survival [J].

Avet-Loiseau, Herve ;

Attal, Michel ;

Campion, Loic ;

Caillot, Denis ;

Hulin, Cyrille ;

Marit, Gerald ;

Stoppa, Anne-Marie ;

Voillat, Laurent ;

Wetterwald, Marc ;

Pegourie, Brigitte ;

Voog, Eric ;

Tiab, Mourad ;

Banos, Anne ;

Jaubert, Jerome ;

Bouscary, Didier ;

Macro, Margaret ;

Kolb, Brigitte ;

Traulle, Catherine ;

Mathiot, Claire ;

Magrangeas, Florence ;

Minvielle, Stephane ;

Facon, Thierry ;

Moreau, Philippe .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) :1949-1952

[7] Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? [J].

Avet-Loiseau, Herve ;

Malard, Florent ;

Campion, Loic ;

Magrangeas, Florence ;

Sebban, Catherine ;

Lioure, Bruno ;

Decaux, Olivier ;

Lamy, Thierry ;

Legros, Laurence ;

Fuzibet, Jean-Gabriel ;

Michallet, Mauricette ;

Corront, Bernadette ;

Lenain, Pascal ;

Hulin, Cyrille ;

Mathiot, Claire ;

Attal, Michel ;

Facon, Thierry ;

Harousseau, Jean-Luc ;

Minvielle, Stephane ;

Moreau, Philippe .

BLOOD, 2011, 117 (06) :2009-2011

[8] Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p) [J].

Avet-Loiseau, Herve ;

Leleu, Xavier ;

Roussel, Murielle ;

Moreau, Philippe ;

Guerin-Charbonnel, Catherine ;

Caillot, Denis ;

Marit, Gerald ;

Benboubker, Lotfi ;

Voillat, Laurent ;

Mathiot, Claire ;

Kolb, Brigitte ;

Macro, Margaret ;

Campion, Loic ;

Wetterwald, Marc ;

Stoppa, Anne-Marie ;

Hulin, Cyrille ;

Facon, Thierry ;

Attal, Michel ;

Minvielle, Stephane ;

Harousseau, Jean-Luc .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4630-4634

[9] Prognostic Significance of Copy-Number Alterations in Multiple Myeloma [J].

Avet-Loiseau, Herve ;

Li, Cheng ;

Magrangeas, Florence ;

Gouraud, Wilfried ;

Charbonnel, Catherine ;

Harousseau, Jean-Luc ;

Attal, Michel ;

Marit, Gerald ;

Mathiot, Claire ;

Facon, Thierry ;

Moreau, Philippe ;

Anderson, Kenneth C. ;

Campion, Loic ;

Munshi, Nikhil C. ;

Minvielle, Stephane .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4585-4590

[10] High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma [J].

Bianchi, G. ;

Kyle, R. A. ;

Larson, D. R. ;

Witzig, T. E. ;

Kumar, S. ;

Dispenzieri, A. ;

Morice, W. G. ;

Rajkumar, S. V. .

LEUKEMIA, 2013, 27 (03) :680-685

← 1 2 3 4 5 6 7 →